239 related articles for article (PubMed ID: 16289487)
1. Antinociception following application of DAMGO to the basolateral amygdala results from a direct interaction of DAMGO with Mu opioid receptors in the amygdala.
Shin MS; Helmstetter FJ
Brain Res; 2005 Dec; 1064(1-2):56-65. PubMed ID: 16289487
[TBL] [Abstract][Full Text] [Related]
2. Antinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla.
Helmstetter FJ; Tershner SA; Poore LH; Bellgowan PS
Brain Res; 1998 Jan; 779(1-2):104-18. PubMed ID: 9473612
[TBL] [Abstract][Full Text] [Related]
3. Microinfusion of mu but not delta or kappa opioid agonists into the basolateral amygdala results in inhibition of the tail flick reflex in pentobarbital-anesthetized rats.
Helmstetter FJ; Bellgowan PS; Poore LH
J Pharmacol Exp Ther; 1995 Oct; 275(1):381-8. PubMed ID: 7562575
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction between TRPV1 and mu-opioid receptors in the descending antinociceptive pathway activates glutamate transmission and induces analgesia.
Maione S; Starowicz K; Cristino L; Guida F; Palazzo E; Luongo L; Rossi F; Marabese I; de Novellis V; Di Marzo V
J Neurophysiol; 2009 May; 101(5):2411-22. PubMed ID: 19297510
[TBL] [Abstract][Full Text] [Related]
6. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.
Tershner SA; Helmstetter FJ
Brain Res; 2000 May; 865(1):17-26. PubMed ID: 10814729
[TBL] [Abstract][Full Text] [Related]
7. Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala.
Finnegan TF; Chen SR; Pan HL
J Pharmacol Exp Ther; 2005 Feb; 312(2):441-8. PubMed ID: 15388784
[TBL] [Abstract][Full Text] [Related]
8. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
9. Activation of mu-opioid receptors inhibits synaptic inputs to spinally projecting rostral ventromedial medulla neurons.
Finnegan TF; Li DP; Chen SR; Pan HL
J Pharmacol Exp Ther; 2004 May; 309(2):476-83. PubMed ID: 14724227
[TBL] [Abstract][Full Text] [Related]
10. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
11. Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G Proteins in the amygdala of fawn-hooded rats.
Chen F; Lawrence AJ
J Pharmacol Exp Ther; 2004 Sep; 310(3):1020-6. PubMed ID: 15121763
[TBL] [Abstract][Full Text] [Related]
12. DAMGO stimulates the hypothalamo-pituitary-adrenal axis through a mu-2 opioid receptor.
Eisenberg RM
J Pharmacol Exp Ther; 1993 Aug; 266(2):985-91. PubMed ID: 8394926
[TBL] [Abstract][Full Text] [Related]
13. Opioid mu receptor activation inhibits sodium currents in prefrontal cortical neurons via a protein kinase A- and C-dependent mechanism.
Witkowski G; Szulczyk P
Brain Res; 2006 Jun; 1094(1):92-106. PubMed ID: 16733049
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of high-fat feeding induced by opioid stimulation of the ventral striatum.
Will MJ; Pratt WE; Kelley AE
Physiol Behav; 2006 Sep; 89(2):226-34. PubMed ID: 16854442
[TBL] [Abstract][Full Text] [Related]
15. Neurotransmitters involved in the opioid regulation of prolactin secretion at the end of pregnancy in rats.
Soaje M; Bregonzio C; Carón RW; Deis RP
Neuroendocrinology; 2004; 80(1):11-20. PubMed ID: 15340248
[TBL] [Abstract][Full Text] [Related]
16. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
17. Intra-amygdalar injection of DAMGO: effects on c-Fos levels in brain sites associated with feeding behavior.
Levine AS; Olszewski PK; Mullett MA; Pomonis JD; Grace MK; Kotz CM; Billington CJ
Brain Res; 2004 Jul; 1015(1-2):9-14. PubMed ID: 15223361
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox.
Peckham EM; Barkley LM; Divin MF; Cicero TJ; Traynor JR
Brain Res; 2005 Oct; 1058(1-2):137-47. PubMed ID: 16139823
[TBL] [Abstract][Full Text] [Related]
19. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J
Mol Pain; 2007 Jul; 3():19. PubMed ID: 17634133
[TBL] [Abstract][Full Text] [Related]
20. Activation of opioid mu receptors in caudal medullary raphe region inhibits the ventilatory response to hypercapnia in anesthetized rats.
Zhang Z; Xu F; Zhang C; Liang X
Anesthesiology; 2007 Aug; 107(2):288-97. PubMed ID: 17667574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]